Table 5.
Frequency of comorbidities, extraglandular, and other common clinical manifestations in SSA- and/or SSB-positive female and male patients with pSS
Women n = 640% (frequency) | Men n = 54% (frequency) | p value | |
---|---|---|---|
Interstitial lung disease | 7% (31/444) | 19% (7/37) | 0.01 |
Enlarged lymph nodes | 10% (57/584) | 16% (8/49) | 0.15 |
Hypothyroidism | 23% (117/517) | 8% (3/40) | 0.03 |
Lymphoma | 4% (28/634) | 11% (6/54) | 0.03 |
Italicized values indicate statistically significant findings (p < 0.05)